Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Correction: ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.

Johnson LA, Zuloaga DG, Bidiman E, Marzulla T, Weber S, Wahbeh H, Raber J.

Neuropsychopharmacology. 2019 Feb;44(3):654. doi: 10.1038/s41386-018-0261-z.

2.

Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice.

Miranda CL, Johnson LA, de Montgolfier O, Elias VD, Ullrich LS, Hay JJ, Paraiso IL, Choi J, Reed RL, Revel JS, Kioussi C, Bobe G, Iwaniec UT, Turner RT, Katzenellenbogen BS, Katzenellenbogen JA, Blakemore PR, Gombart AF, Maier CS, Raber J, Stevens JF.

Sci Rep. 2018 Jan 12;8(1):613. doi: 10.1038/s41598-017-18992-6.

3.

Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.

Johnson LA, Torres ER, Weber Boutros S, Patel E, Akinyeke T, Alkayed NJ, Raber J.

J Cereb Blood Flow Metab. 2017 Jan 1:271678X17746186. doi: 10.1177/0271678X17746186. [Epub ahead of print]

PMID:
29215310
4.

Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome.

Johnson LA, Torres ER, Impey S, Stevens JF, Raber J.

Sci Rep. 2017 Mar 8;7:43701. doi: 10.1038/srep43701.

5.

Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4.

Arbones-Mainar JM, Johnson LA, Torres-Perez E, Garcia AE, Perez-Diaz S, Raber J, Maeda N.

Int J Obes (Lond). 2016 Oct;40(10):1574-1581. doi: 10.1038/ijo.2016.93. Epub 2016 May 10.

6.

Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma.

Johnson LA, Zuloaga KL, Kugelman TL, Mader KS, Morré JT, Zuloaga DG, Weber S, Marzulla T, Mulford A, Button D, Lindner JR, Alkayed NJ, Stevens JF, Raber J.

EBioMedicine. 2015 Dec 12;3:26-42. doi: 10.1016/j.ebiom.2015.12.008. eCollection 2016 Jan.

7.

High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion.

Zuloaga KL, Johnson LA, Roese NE, Marzulla T, Zhang W, Nie X, Alkayed FN, Hong C, Grafe MR, Pike MM, Raber J, Alkayed NJ.

J Cereb Blood Flow Metab. 2016 Jul;36(7):1257-70. doi: 10.1177/0271678X15616400. Epub 2015 Nov 11.

8.

Immediate and lasting effects of chronic daily methamphetamine exposure on activation of cells in hypothalamic-pituitary-adrenal axis-associated brain regions.

Zuloaga DG, Johnson LA, Weber S, Raber J.

Psychopharmacology (Berl). 2016 Feb;233(3):381-92. doi: 10.1007/s00213-015-4114-8. Epub 2015 Nov 2.

9.

ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.

Johnson LA, Zuloaga DG, Bidiman E, Marzulla T, Weber S, Wahbeh H, Raber J.

Neuropsychopharmacology. 2015 Sep;40(10):2443-53. doi: 10.1038/npp.2015.95. Epub 2015 May 10. Erratum in: Neuropsychopharmacology. 2019 Feb;44(3):654.

10.

Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.

Perez-Diaz S, Johnson LA, DeKroon RM, Moreno-Navarrete JM, Alzate O, Fernandez-Real JM, Maeda N, Arbones-Mainar JM.

FASEB J. 2014 Aug;28(8):3769-79. doi: 10.1096/fj.14-251165. Epub 2014 May 8.

11.

Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.

Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J.

Neurobiol Dis. 2014 Apr;64:150-62. doi: 10.1016/j.nbd.2013.12.016. Epub 2014 Jan 9.

12.

Sex differences in activation of the hypothalamic-pituitary-adrenal axis by methamphetamine.

Zuloaga DG, Johnson LA, Agam M, Raber J.

J Neurochem. 2014 May;129(3):495-508. doi: 10.1111/jnc.12651. Epub 2014 Feb 10.

13.

Early effects of whole-body (56)Fe irradiation on hippocampal function in C57BL/6J mice.

Haley GE, Yeiser L, Olsen RH, Davis MJ, Johnson LA, Raber J.

Radiat Res. 2013 May;179(5):590-6. doi: 10.1667/RR2946.1. Epub 2013 Mar 19.

14.

Enhanced hippocampus-dependent memory and reduced anxiety in mice over-expressing human catalase in mitochondria.

Olsen RH, Johnson LA, Zuloaga DG, Limoli CL, Raber J.

J Neurochem. 2013 Apr;125(2):303-13. doi: 10.1111/jnc.12187. Epub 2013 Mar 6.

15.

Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation.

Johnson LA, Kim HS, Knudson MJ, Nipp CT, Yi X, Maeda N.

J Lipid Res. 2013 Feb;54(2):386-96. doi: 10.1194/jlr.M031435. Epub 2012 Nov 30.

16.

Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.

Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1436-44. doi: 10.1161/ATVBAHA.112.248682. Epub 2012 Apr 26.

17.

Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.

Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, Maeda N.

Diabetes. 2011 Sep;60(9):2285-94. doi: 10.2337/db11-0466. Epub 2011 Aug 1.

18.

Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction.

Pendse AA, Johnson LA, Tsai YS, Maeda N.

Diabetes. 2010 Nov;59(11):2890-7. doi: 10.2337/db10-0673. Epub 2010 Aug 19.

19.

Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4.

Arbones-Mainar JM, Johnson LA, Altenburg MK, Kim HS, Maeda N.

FASEB J. 2010 Oct;24(10):3809-18. doi: 10.1096/fj.10-159517. Epub 2010 May 25.

20.

Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond.

Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N.

J Lipid Res. 2009 Apr;50 Suppl:S178-82. doi: 10.1194/jlr.R800070-JLR200. Epub 2008 Dec 5.

Supplemental Content

Loading ...
Support Center